About Glanum Diagnostics
Glanum Diagnostics is a Healthcare company based in Weert (Netherlands) founded in 2018. ECG diagnosis equipment is supplied for single-day cardiac monitoring. Glanum Diagnostics offers products and services including Holter Registration, Event Recording, and Blood Pressure Measurement. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Screening Devices. Its legal entity is Stichting Glanum Diagnostics.
Company details
Glanum Diagnostics was established in 2018 in Weert, Netherlands, within the medical diagnostics sector. Equipment for ECG-based cardiac response recording over a 24-hour period is offered by the company. Operations focus on diagnostic tools compliant with ISO 13485 standards, supporting healthcare providers in cardiac assessments across the region.
- Headquarters Weert, Netherlands
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website glanum-diagnostics.com
- Legal Name Stichting Glanum Diagnostics
- Latest Funding Round$55.6K (USD), Grant
Oct 2019
- InvestorsEuropean Union
& 1 more
Products & Services of Glanum Diagnostics
Glanum Diagnostics offers a comprehensive portfolio of products and services, including Holter Registration, Event Recording, and Blood Pressure Measurement.
Service for 24-48 hour heart activity recording and analysis.
Monitors events up to five days for irregularity detection.
Provides 24-hour tracking of blood pressure levels.
Funding Insights of Glanum Diagnostics
- Total Rounds 2
- Last Round Grant — $55,601
- First Round $56,002
(May 2019)
- Investors Count 2
All 2 funding rounds of Glanum Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | $55,601 | Grant | – | – | |
| May 2019 | $56,002 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Glanum Diagnostics
Glanum Diagnostics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Glanum Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Glanum Diagnostics
3 dated milestones of Glanum Diagnostics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Glanum Diagnostics is founded.
- Funding First funding round of $56K.
- Funding Latest funding round, Grant, of $56K.
Web traffic of Glanum Diagnostics
The website of Glanum Diagnostics (glanum-diagnostics.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 4617.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Glanum Diagnostics
Glanum Diagnostics was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Glanum Diagnostics is headquartered in Weert, Netherlands. It is registered at Weert, Limburg, Netherlands.
Glanum Diagnostics was established in 2018 in Weert, Netherlands, within the medical diagnostics sector. Equipment for ECG-based cardiac response recording over a 24-hour period is offered by the company. Operations focus on diagnostic tools compliant with ISO 13485 standards, supporting healthcare providers in cardiac assessments across the region.
Glanum Diagnostics offers Holter Registration, Event Recording, and Blood Pressure Measurement.
Glanum Diagnostics has 2 investors. Key investors include European Union, and EIC Fund.
Glanum Diagnostics operates through Stichting Glanum Diagnostics.